Expertise in
6
conditions

Tingbo B. Liang

79 Qingchun Road, 
Hangzhou, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
79 Qingchun Road, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Tingbo Liang practices in Hangzhou, China. Liang is highly rated in 6 conditions, according to our data. Their top areas of expertise are Pancreatic Cancer, Liver Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Liver Transplant.

Their clinical research consists of co-authoring 292 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

79 Qingchun Road, Hangzhou, 310003, China
Other Locations
Zhejiang University No. 79 Qingchun Road, Hangzhou, 310003, China
Jiefang Road 88, Hangzhou, 310009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Dose Ascending, Open Phase I Clinical Study to Evaluate the Safety, Tolerability , Pharmacokinetics Characteristics and Preliminary Effectiveness of VG161 in Subjects with Advanced Primary Liver Cancer
A Dose Ascending, Open Phase I Clinical Study to Evaluate the Safety, Tolerability , Pharmacokinetics Characteristics and Preliminary Effectiveness of VG161 in Subjects with Advanced Primary Liver Cancer
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Study Phase: Phase 1
An Open, Dose Escalation/Dose Exploration, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single/Multiple Infusion of CT0180 Injection in Patients With Advanced Hepatocellular Carcinoma
An Open, Dose Escalation/Dose Exploration, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single/Multiple Infusion of CT0180 Injection in Patients With Advanced Hepatocellular Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Drug
Study Drug: CT0180 Cells
Study Phase: Phase 1
A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drug: ZW25 (Zanidatamab)
Study Phase: Phase 2
A Phase I Clinical Study of 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 ( CAR-GPC3 T Cells) in Patients With Advanced Hepatocellular Carcinoma
A Phase I Clinical Study of 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 ( CAR-GPC3 T Cells) in Patients With Advanced Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Drug
Study Drug: CAR-GPC3 T Cells
Study Phase: Phase 1
View 3 Less Clinical Trials

292 Total Publications

Oncolytic viruses: Revolutionising the fight against tumours.
Oncolytic viruses: Revolutionising the fight against tumours.
Journal: Clinical and translational medicine
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liang's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile